Cook Group Incorporated: Peripheral Arterial Disease trials

The registry lists 16 Peripheral Arterial Disease studies with Cook Group Incorporated as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 2 1No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• EVERO Drug-coated Balloon (DCB) Randomized TrialRecruitingNCT07144150Not applicable
• Zilver PTX Delivery SystemCompletedNCT02271529Not applicableResults posted
• Zilver® PTX® V Clinical StudyCompletedNCT01901289Not applicableResults posted
• Zilver PTX Drug-Eluting Peripheral Stent StudyCompletedNCT01348425Not applicableResults posted
• Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal ArteryCompletedNCT00120406Not applicableResults posted
• Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal StenosesCompletedNCT02936622Not applicable
• Zilver PTX Post-Market Study in JapanCompletedNCT02254837Not applicable
• Zilver Flex Post-Market Study in JapanCompletedNCT02254356Not applicable
• Zilver® PTX® in ChinaCompletedNCT02171962Not applicable
• Pilot Safety Study of Injectable SIS for Critical Limb IschemiaCompletedNCT02145845Not applicable
• Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb IschemiaCompletedNCT02044666Not applicable
• Tibiopedal Access for Crossing of Infrainguinal Artery OcclusionsCompletedNCT01609621
• Zilver® PTX™ Global RegistryCompletedNCT01094678Not applicable
• Zilver® Flex™ Vascular Stent StudyCompletedNCT00827619Not applicable
• Advance® 18PTX® Balloon Catheter StudyCompletedNCT00776906Not applicable
• Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)CompletedNCT00196066Phase 2